CKRA HELPS DEVELOP THE MEDICINES OF TOMORROW!
CURRENT STUDIES
- Adolescent HPV/Meningitis Vaccine
- Adolescent Migraines
- Adolescent Smoking Cessation
- Asthma
- Female Sexual Dysfunction
- Fibromyalgia
- Fibromyalgia and Depression
- Gout (Lexington office)
- Gout (Mt. Sterling office)
- Low Testosterone
- Nocturia
- Overactive Bladder
- Smoking Cessation
- Type 2 Diabetes (study #1 - Mt. Sterling office)
- Type 2 Diabetes (study #2 - Mt. Sterling office)
-
VIEW ALL STUDIES: Lexington Mt. Sterling
SIGN UP – STUDY WAITING LIST
TESTIMONIALS
"It has been a pleasure for me to be a study participant in the important research going on at CKRA. It is exciting to be part of a study of new drugs and procedures being investigated.
The staff at Central Kentucky Research Associates is very professional; and has scheduled me in an organized and timely manner to fit my personal schedule.
Dr. James Borders and his staff are dedicated and committed individuals and a joy to work with. I personally find promise with the work they do for their clients and participants."
JCG, Lexington
Study ParticipantCKRA ON FACEBOOK
Current Studies
The purpose of this study is to find out if an investigational meningitis vaccine is safe and can help prevent meningococcal disease when given to healthy children ages 11 to 17 years old. Duration: Up to 14 months Number of … Read more
The purpose of this study is to find out if the investigational medication, Zomig nasal spray, will help relieve migraine pain in adolescents ages 12 to 17 years old. Duration: Approximately 14 weeks Number of visits to CKRA: 3 Compensation: … Read more
The purpose of this study is to evaluate the safety, efficacy, and tolerability of Chantix versus a placebo in adolescent smokers who are motivated to quit smoking. Duration: Up to 1 year Number of visits to CKRA: At least 23 … Read more
The purpose of this study is to help determine whether patients taking inhaled corticosteroids together with salmeterol have the same risk of having uncommon but serious problems due to asthma when compared to patients taking inhaled corticosteroids alone. Duration: Approximately … Read more
The purpose of this study is to determine if an investigational medication called bremelanotide is effective for treating women with female sexual arousal disorder (FSAD) and / or hypoactive sexual desire disorder (HSDD), compared to a placebo. Duration: Approximately 23 … Read more
The purpose of this study is to compare the safety and effectiveness of an investigational formulation of Pregabalin. Duration: Approximately 21 weeks Number of visits to CKRA: Up to 10 Compensation: Up to $350 for completion NOTE: Qualified participants must … Read more
The purpose of this study is to identify and treat subjects who have both fibromyalgia and depression who are taking an antidepressant for their depression, and to determine whether pregabalin improves pain associated with fibromyalgia compared to a placebo in … Read more
The purpose of this study is to evaluate Colcrys (colchicine) given once daily compared to a placebo in patients with gout who are starting uric acid-lowering therapy with allopurinol. Duration: Approximately 20 weeks Number of visits to CKRA: Up to … Read more
The purpose of this study is to further evaluate the efficacy of Krystexxa in adult patients with gout. Duration: Approximately 63 weeks Number of visits to CKRA: Approximately 25 Compensation: $30 per completed visit NOTE: Qualified participants must be at … Read more
The purpose of this study is to evaluate the safety and effectiveness of an investigational medication in male subjects with low testosterone, otherwise known as “hypogonadism”. Duration: Up to 58 weeks Number of visits to CKRA: Up to 17 Compensation: … Read more
The purpose of this study is to compare the effectiveness and tolerability of three concentrations of an investigational nasal spray versus a placebo nasal spray for the treatment of nocturia. Duration: Approximately 16 weeks Number of visits to CKRA: Up … Read more
The purpose of this study is to compare the effectiveness of two doses of a drug called fesoterodine to a placebo for overactive bladder. Duration: Up to 16 weeks Number of visits to CKRA: 3 to 4 Compensation: Up to … Read more
The purpose of this study is to examine important safety aspects of the drugs varenicline (Chantix) and buproprion (Wellbutrin, Zyban) compared to nictoine-replacement therapy (nicotine patch) and placebo in smokers and to examine how well varenicline, buproprion and nicotine-replacement therapy will … Read more
The purpose of this study is to evaluate cardiovascular outcomes after treatment with Exenatide once weekly in patients with Type 2 Diabetes. Duration: Approximately 4 years Number of visits to CKRA: Approximately 12 Compensation: Up to $30 per completed visit … Read more
The purpose of this study is to evaluate the safety and efficacy of a new medication and stigaliptin (Januvia) added to metformin in adult patients who are not adequately controlled on metformin alone or in combination with other diabetes medications. … Read more
